SEC Comment Letter 0000000000-23-008883 to CalciMedica, Inc. (CALC)
CalciMedica, Inc.
Date: Aug. 15, 2023 · CIK: 0001534133 · Accession: 0000000000-23-008883
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273949
Letter
United States securities and exchange commission logo August 15, 2023 Rachel Leheny Chief Executive Officer CalciMedica, Inc. 505 Coast Boulevard South, Suite 307 La Jolla, CA 92037 Re:CalciMedica, Inc. Registration Statement on Form S-3 Filed August 11, 2023 File No. 333-273949 Dear Rachel Leheny: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Tom Coll
Show Raw Text
United States securities and exchange commission logo
August 15, 2023
Rachel Leheny
Chief Executive Officer
CalciMedica, Inc.
505 Coast Boulevard South, Suite 307
La Jolla, CA 92037
Re:CalciMedica, Inc.
Registration Statement on Form S-3
Filed August 11, 2023
File No. 333-273949
Dear Rachel Leheny:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Tom Coll